Related Experiment Video
Updated: Jul 19, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Human papillomavirus type 5 E6 oncoprotein represses the transforming growth factor beta signaling pathway by binding
Jose-Andres Mendoza1, Yves Jacob, Patricia Cassonnet
1Unité postulante de Génétique, Papillomavirus et Cancer Humain, Institut Pasteur, 25 rue du Docteur Roux, 75724 Paris Cedex, France.
Abstract:
Mechanisms of cellular transformation associated with human papillomavirus type 5 (HPV5), which is responsible for skin carcinomas in epidermodysplasia verruciformis (EV) patients, are poorly understood. Using a yeast two-hybrid screening and molecular and cellular biology experiments, we found that HPV5 oncoprotein E6 interacts with SMAD3, a key component in the transforming growth factor beta1 (TGF-beta1) signaling pathway. HPV5 E6 inhibits SMAD3 transactivation by destabilizing the SMAD3/SMAD4 complex and inducing the degradation of both proteins. Interestingly, the E6 protein of nononcogenic EV HPV9 failed to interact with SMAD3, suggesting that downregulation of the TGF-beta1 signaling pathway could be a determinant in HPV5 skin carcinogenesis.
Insights
Human papillomavirus type 5 (HPV5) E6 protein disrupts skin cell growth by targeting SMAD3 in the TGF-beta1 pathway. This interaction destabilizes key proteins, potentially driving skin cancer in epidermodysplasia verruciformis (EV) patients.
Area of Science:
- Molecular biology
- Virology
- Cancer research
Background:
- Human papillomavirus type 5 (HPV5) causes skin carcinomas in epidermodysplasia verruciformis (EV).
- Mechanisms of HPV5-induced cellular transformation are not fully understood.
- The transforming growth factor beta1 (TGF-beta1) signaling pathway is crucial in cellular regulation.
Purpose of the Study:
- To investigate the molecular mechanisms of HPV5-mediated cellular transformation.
- To identify interactions between HPV5 oncoproteins and host cell factors.
- To elucidate the role of the TGF-beta1 pathway in HPV5-associated carcinogenesis.
Main Methods:
- Yeast two-hybrid screening to identify protein interactions.
- Molecular and cellular biology techniques to validate interactions and assess protein function.
- Analysis of protein complex stability and degradation pathways.
Main Results:
- HPV5 oncoprotein E6 directly interacts with SMAD3, a critical component of the TGF-beta1 pathway.
- HPV5 E6 binding leads to the destabilization and degradation of the SMAD3/SMAD4 complex.
- E6 protein from a non-oncogenic HPV (HPV9) did not interact with SMAD3.
Conclusions:
- HPV5 E6 disrupts TGF-beta1 signaling by targeting SMAD3, inhibiting its transactivation function.
- The downregulation of the TGF-beta1 pathway by HPV5 E6 is a potential mechanism for skin carcinogenesis in EV.
- Targeting the HPV5 E6-SMAD3 interaction may offer therapeutic strategies for HPV-associated skin cancers.
Related Concept Videos
TGF - β Signaling Pathway
Abnormal Proliferation
Hedgehog Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
The JAK-STAT Signaling Pathway

